{"document": {"publication": "Tag My News", "full_text": "the u.s. health regulator on wednesday approved astrazeneca plc's medullary thyroid cancer drug, vandetanib, the first treatment to be approved for the rare form of cancer.", "title": "fda approves astrazeneca's thyroid cancer drug", "line_count": 1, "filename": "3619", "publication_date": "06-04-2011 22:30:18", "lines_and_colors": [["the u.s. health regulator on wednesday approved astrazeneca plc's medullary thyroid cancer drug, vandetanib, the first treatment to be approved for the rare form of cancer.", {}]]}}